CVR 46754565Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)HørsholmFounded 25 Aug 2026
CVR holds no employment figures for this company.
CVR holds no annual report for this company.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Threepoint Therapeutics ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexBukwang Pharmaceutical Co., Ltd100% of capital and votes, since 25 Aug 2026
Thomas Nikolaj Sagersince 25 Aug 2026
100% of capital and votessince 25 Aug 2026
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
25 Aug 2026 to 7 Nov 2026.
Threepoint Therapeutics ApS was recently founded and may need suppliers and advisors.
Signal, a Dandex estimate. Lapses 6 Mar 2027.
Each registered value from the day it took effect, newest first.
Demerger (Spaltning), as the receiving company (Modtagende selskab)
From CVR, read 7 Nov 2026. Text such as the signing rule and purpose is shown as registered.
1 registration, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående spaltning.
Virksomheden er d. 25.08.2026 opstået efter spaltning. Aktiver og gæld er overdraget fra CVR-nummer: 33062214 CONTERA PHARMA A/S.
Seneste vedtægtsdato: 25.08.2026.
Kapital:
kr. 20.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt ved spaltning kr. 20.000,00 til kurs 352.228,98, fuldt indbetalt.
Bestyrelse:
Mi Chung Ahn, (formand), den 25.08.2026, Thomas Nikolaj Sager, den 25.08.2026, Jaeyoung Lee, den 25.08.2026, Mahmoud Mahmoudian, den 25.08.2026, Woohyun Lee, den 25.08.2026.
Direktion:
Thomas Nikolaj Sager, (adm. dir), den 25.08.2026.
Selskabet tegnes af bestyrelsesformanden i forening med selskabets administrerende direktør.
Revision:
CVR-NR. 14119299 PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab, Hovedvejen 56, 2600 Glostrup, den 25.08.2026.
Første regnskabsår:
01.01.2026 - 31.12.2026.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at forske i RNA-baserede teknologier med henblik på at udvikle RNA-baserede lægemidler.
1 registered in CVR.
P-number 1032748771Venlighedsvej 4, 2970 Hørsholm
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
